- Home
- NYT vs BRKR Comparison
NYT vs BRKR Comparison
Compare NYT & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYT
- BRKR
- Stock Information
- Founded
- NYT 1851
- BRKR 1991
- Country
- NYT United States
- BRKR United States
- Employees
- NYT N/A
- BRKR N/A
- Industry
- NYT Newspapers/Magazines
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- NYT Consumer Discretionary
- BRKR Industrials
- Exchange
- NYT Nasdaq
- BRKR Nasdaq
- Market Cap
- NYT 9.1B
- BRKR 9.9B
- IPO Year
- NYT N/A
- BRKR 2000
- Fundamental
- Price
- NYT $54.15
- BRKR $65.28
- Analyst Decision
- NYT Buy
- BRKR Buy
- Analyst Count
- NYT 5
- BRKR 10
- Target Price
- NYT $50.60
- BRKR $80.11
- AVG Volume (30 Days)
- NYT 710.8K
- BRKR 910.3K
- Earning Date
- NYT 11-06-2024
- BRKR 10-31-2024
- Dividend Yield
- NYT 0.97%
- BRKR 0.30%
- EPS Growth
- NYT 52.50
- BRKR 10.49
- EPS
- NYT 1.62
- BRKR 2.39
- Revenue
- NYT $2,467,072,000.00
- BRKR $3,119,700,000.00
- Revenue This Year
- NYT $8.54
- BRKR $17.05
- Revenue Next Year
- NYT $6.68
- BRKR $9.28
- P/E Ratio
- NYT $33.07
- BRKR $27.42
- Revenue Growth
- NYT 5.50
- BRKR 14.93
- 52 Week Low
- NYT $39.73
- BRKR $53.79
- 52 Week High
- NYT $56.49
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- NYT 51.15
- BRKR 53.15
- Support Level
- NYT $52.23
- BRKR $61.74
- Resistance Level
- NYT $54.90
- BRKR $66.13
- Average True Range (ATR)
- NYT 0.81
- BRKR 2.06
- MACD
- NYT -0.15
- BRKR 0.04
- Stochastic Oscillator
- NYT 46.74
- BRKR 49.79
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the major source of revenue for both segments is subscription.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.